Dr. David I. Quinn
Claim this profileUSC / Norris Comprehensive Cancer Center
Studies Prostate Cancer
Studies Bladder Cancer
8 reported clinical trials
19 drugs studied
Area of expertise
1Prostate Cancer
Stage IV
2Bladder Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials David I. Quinn is currently running
Radium-223 + M3814 + Avelumab
for Prostate Cancer
This phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in treating patients with castrate-resistant prostate cancer that had spread to other places in the body (metastatic). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radioactive drugs, such as radium-223 dichloride, may carry radiation directly to tumor cells and not harm normal cells. Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This study is being done to find out the better treatment between radium-223 dichloride alone, radium-223 dichloride in combination with M3814, or radium-223 dichloride in combination with both M3814 and avelumab, to lower the chance of prostate cancer growing or spreading in the bone, and if this approach is better or worse than the usual approach for advanced prostate cancer not responsive to hormonal therapy.
Recruiting1 award Phase 1 & 2
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting2 awards Phase 316 criteria
More about David I. Quinn
Clinical Trial Related12 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments David I. Quinn has experience with
- Eribulin Mesylate
- Avelumab
- Controlled Low Calorie Diet
- Short-term Fasting
- Modified Fast
- Fasting
Breakdown of trials David I. Quinn has run
Prostate Cancer
Bladder Cancer
Kidney Cancer
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David I. Quinn specialize in?
David I. Quinn focuses on Prostate Cancer and Bladder Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is David I. Quinn currently recruiting for clinical trials?
Yes, David I. Quinn is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that David I. Quinn has studied deeply?
Yes, David I. Quinn has studied treatments such as Eribulin Mesylate, Avelumab, Controlled Low Calorie Diet.
What is the best way to schedule an appointment with David I. Quinn?
Apply for one of the trials that David I. Quinn is conducting.
What is the office address of David I. Quinn?
The office of David I. Quinn is located at: USC / Norris Comprehensive Cancer Center, Los Angeles, California 90033 United States. This is the address for their practice at the USC / Norris Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.